Johannes-Peter Stasch


Ontology type: schema:Person     


Person Info

NAME

Johannes-Peter

SURNAME

Stasch

Publications in SciGraph latest 50 shown

  • 2021-09-22 Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease in NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY
  • 2019-07-05 Correction to: Soluble Guanylate Cyclase Stimulators and Activators in REACTIVE OXYGEN SPECIES
  • 2019-02-13 Singlet molecular oxygen regulates vascular tone and blood pressure in inflammation in NATURE
  • 2018 Soluble Guanylate Cyclase Stimulators and Activators in REACTIVE OXYGEN SPECIES
  • 2017-10-10 Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2015-10-07 Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice in NATURE COMMUNICATIONS
  • 2015-09-02 The sGC stimulator BAY 41-8543 in a rat model of hypertension-induced heart failure in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2015-09-02 Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2015-09-02 Riociguat and cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2015-09-02 sGC redox regulation and asthma in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2015-05-26 Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue in NATURE COMMUNICATIONS
  • 2015 Translational In Vivo Models for Cardiovascular Diseases in NEW APPROACHES TO DRUG DISCOVERY
  • 2013-08-29 The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2013-08-29 Increases survival by apo-sGC activation via post-stroke blood brain barrier stabilisation and anti-inflammation in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2013-08-29 Urinary cGMP concentrations after exposure to radio-contrast media in patient at risk for contrast media induced nephropathy (CIN) predicts 90-day morbidity and mortality in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2013-08-29 Chronic activation of heme free soluble guanylate cyclase leads to cardio-renal protection in experimental hypertension in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2013-08-06 Soluble Guanylate Cyclase Stimulators in Pulmonary Hypertension in PHARMACOTHERAPY OF PULMONARY HYPERTENSION
  • 2013-08-06 Soluble Guanylate Cyclase Stimulators in Pulmonary Hypertension in NONE
  • 2013-04-29 Receptor Binding Assay for NO-Independent Activators of Soluble Guanylate Cyclase in GUANYLATE CYCLASE AND CYCLIC GMP
  • 2012-05-24 Soluble guanylate cyclase: a potential therapeutic target for heart failure in HEART FAILURE REVIEWS
  • 2011-09-14 Erratum to: Improvement of right heart structure and function by BAY41-8543 in pulmonary artery banded mice in BMC PHARMACOLOGY
  • 2011-08-01 Nitric oxide-independent stimulation of soluble guanylate cyclase attenuates pulmonary fibrosis in BMC PHARMACOLOGY
  • 2011-08-01 Riociguat prevents fibrotic tissue remodelling and improves survival in salt-sensitive Dahl rats in BMC PHARMACOLOGY
  • 2011-08-01 Evidence for two catalytic centers and Mn2+ as physiological cofactor of soluble guanylyl cyclase in BMC PHARMACOLOGY
  • 2011-08-01 Effects of riociguat in severe experimental pulmonary hypertension in BMC PHARMACOLOGY
  • 2011-08-01 The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats in BMC PHARMACOLOGY
  • 2011-08-01 Improvement of right heart structure and function by BAY 41-8543 in pulmonary artery banded mice in BMC PHARMACOLOGY
  • 2011-08-01 Biomarkers in two different animal models of pulmonary arterial hypertension (PAH) under treatment with a cGMP enhancing substance in BMC PHARMACOLOGY
  • 2011-08-01 Activation of heme-free soluble guanylate cyclase with cinaciguat has beneficial cardiorenal actions when added to furosemide in experimental heart failure in BMC PHARMACOLOGY
  • 2011-08-01 Structural insights into sGC activation by different activators in BMC PHARMACOLOGY
  • 2011-08-01 Comparison of different vasodilators, endothelin antagonist, PDE5 inhibitior and sGC stimulators, in an animal model of secondary pulmonary hypertension: effects on “desaturation” in BMC PHARMACOLOGY
  • 2011-08-01 Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone in BMC PHARMACOLOGY
  • 2011-08-01 Relaxant effect of BAY 41-2272 and BAY 58-2667 in the gastrointestinal tract of apo-sGC mice in BMC PHARMACOLOGY
  • 2010-05 Erratum: Corrigendum: Kynurenine is an endothelium-derived relaxing factor produced during inflammation in NATURE MEDICINE
  • 2010-02-28 Kynurenine is an endothelium-derived relaxing factor produced during inflammation in NATURE MEDICINE
  • 2009-08-11 Nucleotidyl cyclase activity of recombinant soluble guanylyl cyclase in BMC PHARMACOLOGY
  • 2009-08-11 The uremic retention solute p-cresyl sulfate alters NO signal transduction by alteration of the soluble guanylate cyclase redox state in BMC PHARMACOLOGY
  • 2009-08-11 Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension in BMC PHARMACOLOGY
  • 2009-08-11 Antihypertrophic actions of NO-independent soluble guanylyl cyclase (sGC) ligands BAY 41-2272 and BAY 58-2667 in vitro in BMC PHARMACOLOGY
  • 2009-08-11 sGC activators and stimulators attenuate ischemia/reperfusion injury of the lung in BMC PHARMACOLOGY
  • 2009-08-11 Cardio-renal protection of riociguat (BAY 63-2521) in low- and high-renin models of hypertension in BMC PHARMACOLOGY
  • 2009-08-11 Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation in BMC PHARMACOLOGY
  • 2009-08-11 NO-insensitive sGCbeta1 H105F knockin mice: if NO has no place to go in BMC PHARMACOLOGY
  • 2009-08-11 Phenotypes of sGC mutant mice in basic conditions, disease and shock in BMC PHARMACOLOGY
  • 2009-08-11 Cardioprotective effects in aged spontaneously hypertensive rats due to chronic stimulation/activation of sGC without hypotension in BMC PHARMACOLOGY
  • 2009-08-11 Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteosomal degradation in BMC PHARMACOLOGY
  • 2009-08-11 Kynurenine is a novel endothelium-derived vascular relaxing factor produced during inflammation in BMC PHARMACOLOGY
  • 2009-08-11 Acute hemodynamic response to single oral doses of BAY 60-4552, a soluble guanylate cyclase stimulator, in patients with biventricular heart failure in BMC PHARMACOLOGY
  • 2009-08-11 Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass in BMC PHARMACOLOGY
  • 2009-08-11 Is kynurenine a novel and important vasodilator in human septic shock? in BMC PHARMACOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.420044.6", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.11348.3f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.500380.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412004.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.32224.35", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7551.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418209.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.491867.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7886.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9018.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6190.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411067.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5110.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.66875.3a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7445.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6363.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410849.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7727.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1002.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8664.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8379.5", 
            "type": "Organization"
          }
        ], 
        "familyName": "Stasch", 
        "givenName": "Johannes-Peter", 
        "id": "sg:person.01341701413.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341701413.12"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-05-10T11:28", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/person/person_683.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01341701413.12'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01341701413.12'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01341701413.12'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01341701413.12'


     

    This table displays all metadata directly associated to this object as RDF triples.

    56 TRIPLES      10 PREDICATES      31 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01341701413.12 schema:affiliation N452cae0bac8c47f6b5bcd0e53ca95c87
    2 grid-institutes:grid.1002.3
    3 grid-institutes:grid.11348.3f
    4 grid-institutes:grid.32224.35
    5 grid-institutes:grid.410849.0
    6 grid-institutes:grid.411067.5
    7 grid-institutes:grid.412004.3
    8 grid-institutes:grid.418209.6
    9 grid-institutes:grid.491867.5
    10 grid-institutes:grid.500380.e
    11 grid-institutes:grid.5110.5
    12 grid-institutes:grid.6190.e
    13 grid-institutes:grid.6363.0
    14 grid-institutes:grid.66875.3a
    15 grid-institutes:grid.7445.2
    16 grid-institutes:grid.7551.6
    17 grid-institutes:grid.7727.5
    18 grid-institutes:grid.7886.1
    19 grid-institutes:grid.8379.5
    20 grid-institutes:grid.8664.c
    21 grid-institutes:grid.9018.0
    22 schema:familyName Stasch
    23 schema:givenName Johannes-Peter
    24 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341701413.12
    25 schema:sdDatePublished 2022-05-10T11:28
    26 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    27 schema:sdPublisher N935b8e3c863a42dea383deb260a76ae3
    28 sgo:license sg:explorer/license/
    29 sgo:sdDataset persons
    30 rdf:type schema:Person
    31 N452cae0bac8c47f6b5bcd0e53ca95c87 schema:affiliation grid-institutes:grid.420044.6
    32 sgo:isCurrent true
    33 rdf:type schema:OrganizationRole
    34 N935b8e3c863a42dea383deb260a76ae3 schema:name Springer Nature - SN SciGraph project
    35 rdf:type schema:Organization
    36 grid-institutes:grid.1002.3 schema:Organization
    37 grid-institutes:grid.11348.3f schema:Organization
    38 grid-institutes:grid.32224.35 schema:Organization
    39 grid-institutes:grid.410849.0 schema:Organization
    40 grid-institutes:grid.411067.5 schema:Organization
    41 grid-institutes:grid.412004.3 schema:Organization
    42 grid-institutes:grid.418209.6 schema:Organization
    43 grid-institutes:grid.420044.6 schema:Organization
    44 grid-institutes:grid.491867.5 schema:Organization
    45 grid-institutes:grid.500380.e schema:Organization
    46 grid-institutes:grid.5110.5 schema:Organization
    47 grid-institutes:grid.6190.e schema:Organization
    48 grid-institutes:grid.6363.0 schema:Organization
    49 grid-institutes:grid.66875.3a schema:Organization
    50 grid-institutes:grid.7445.2 schema:Organization
    51 grid-institutes:grid.7551.6 schema:Organization
    52 grid-institutes:grid.7727.5 schema:Organization
    53 grid-institutes:grid.7886.1 schema:Organization
    54 grid-institutes:grid.8379.5 schema:Organization
    55 grid-institutes:grid.8664.c schema:Organization
    56 grid-institutes:grid.9018.0 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...